Últimos Artículos de Lancet Diabetes & Endocrinology
- [Correspondence] Do weight loss and weight cycling present a clinically meaningful risk in older patients?
- [Editorial] Soaring GLP-1 receptor agonist use
- [Editorial] Energy drink ban: putting children's health first
- [Viewpoint] Goal-directed osteoporosis treatment: are bone mineral density targets valid?
- [Review] Nutritional, functional, and psychological considerations for incretin-based therapies in adults—an EASO, EFAD, and ECPO Consensus Statement
- [Articles] Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study
- [Articles] Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial
- [Comment] Insulin and health systems in global low-resource settings
- [Correspondence] Weight management in China: integrating mental health into routine obesity care
- [Editorial] Out of touch medical care
- [Editorial] Innovation is key to transforming future obesity care
- [In Focus] ADA Scientific Sessions 2026: a line crossed
- [Personal View] Intermittent fasting to treat diabetes: time to update clinical practice guidelines
- [Comment] Endocrine–neuropsychological interplay underpinning maternal postpartum depression
- [Comment] An important new data source for obesity trends in England
- [Articles] Whole-population trends in obesity across dimensions of inequality in England, 2019–25: a retrospective, longitudinal cohort study of 54 million adults
- [Correspondence] High cost and poor availability of continuous glucose monitoring in low-income and middle-income countries
- [Correspondence] Diabetic foot ulcer prevention in Kuwait
- [Corrections] Correction to Lancet Diabetes Endocrinol 2026; published online June 7. https://doi.org/10.1016/S2213-8587(26)00125-7
- [Comment] Obesity medications versus metabolic bariatric surgery: the debate goes on